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The number of carotid endarterectomies being
performed in this country is steadily increasing, with
conclusive data that demonstrate the benefits of
carotid endarterectomy in both the North American
Symptomatic Carotid Endarterectomy Trial1 and
the Asymptomatic Carotid Atherosclerosis Study.2
Although some investigators have questioned the
benefit of postoperative surveillance of the repaired
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Objective: The ideal method of arterial reconstruction in operations for recurrent carotid
disease after prior endarterectomy is unknown. The goal of this study was to review a
series of carotid reoperations and to determine whether the surgical technique influ-
enced the rate of perioperative stroke, late stroke, or secondary restenosis.
Methods: A retrospective review was conducted of 82 carotid reoperations performed on
74 patients at our institution.
Results: The patient population included 39 men (52.7%) and 35 women (47.3%), with a
mean age of 67.5 years. The indications for redo surgery included transient ischemic attack
or amaurosis fugax in 35.3% of the patients, stroke in 6.1%, and asymptomatic restenosis
(>80%) in 58.5%. Patch angioplasty with or without redo endarterectomy was used in 47
cases (57.3%), with saphenous vein in 26 (31.7%), Dacron in 15 (18.3%), and polytetraflu-
oroethylene in 6 (7.3%). Interposition grafting was used in 35 cases (42.7%), with saphe-
nous vein in 9 (11.0%), Dacron in 10 (12.2%), and polytetrafluoroethylene in 16 (19.5%).
The perioperative complications included three strokes (3.7%). There was a trend toward
increased perioperative neurologic complications with interposition grafting when com-
pared with patch angioplasty (8.6% vs 2.1%), although this did not reach statistical signifi-
cance. Long-term clinical follow-up was obtained in all cases with a mean duration of 35
months, with follow-up duplex scanning performed in 89.2%. The late failures of redo
surgery included four significant secondary restenoses and five total occlusions. There was
a trend towards improved long-term results with interposition grafting as opposed to patch
angioplasty. However, the cases in which reconstruction was performed with a vein had a
significantly higher rate of late failures (stroke, secondary recurrent stenosis, or occlusion)
than those in which reconstruction was performed with any prosthetic material (26.7% vs
2.3%; P = .002 by Fisher exact test).
Conclusion: The use of autologous material for redo carotid surgery in any configuration
appears to significantly increase the rate of subsequent recurrent stenosis or total occlusion
of the operated artery. The reason for this finding is unclear but may be related to both
host and technical factors. Prosthetic material may be more durable in the long-term for
redo carotid surgery. Interposition grafting for redo carotid surgery may increase the peri-
operative neurologic complication rate to some degree; however, this was not statistically
significant in this series. Interposition grafting may be a more durable solution in long-
term follow-up than redo endarterectomy and patch angioplasty. A longer follow-up peri-
od will be needed to confirm this conclusion. (J Vasc Surg 1999;29:72-81.)
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carotid artery, others maintain that sequential
duplex scanning of the operated artery is crucial for
a number of reasons—the detection of recurrent
carotid artery stenosis is one of these objectives.
Estimates of the incidence rate of recurrent stenosis
after prior endarterectomy vary widely in the litera-
ture, ranging from 1.2% to 36.0% in a number of
published series.3-8 The possible role of endovascu-
lar treatment of recurrent carotid stenoses is anoth-
er variable that has recently entered this equation.9,l0
The approach to recurrent carotid stenosis at our
institution has been to surgically repair these lesions
with similar indications as primary carotid stenoses.3,4
It has been shown that the operations for recurrent
carotid artery disease can be performed without a sig-
nificantly increased risk of perioperative stroke, cranial
nerve injury, or mortality.3,4 However, an earlier
review of a series of cases at our institution had
revealed another concern. The incidence rate of late
failure after redo surgery was 19.5% (8 of 41
patients).3 The failures consisted of one stroke, three
transient ischemic attacks, and four asymptomatic
occlusions. We were concerned about these data,
which revealed that perhaps surgery for carotid
restenosis was less durable than primary carotid
endarterectomy. Most of the reoperations that were
reviewed in this series consisted of redo endarterecto-
my with vein patch angioplasty. After these previous
data were published, we speculated that perhaps inter-
position grafting would be a more suitable operation
for recurrent carotid artery disease. The goal of this
study was to review a series of carotid reoperations
and to determine whether a change in the surgical
technique influenced the rate of perioperative stroke,
late stroke, or secondary restenosis.
PATIENTS AND METHODS
The records of all the patients who underwent
carotid surgery from 1980 through 1996 were
examined from a prospectively compiled computer-
ized database on all patients who undergo cerebral
vascular surgery in the Division of Vascular Surgery
of the New York University Medical Center. Patients
who underwent one or more operations for recur-
rent carotid artery disease during this period and
whose original carotid operation occurred during or
after the year 1980 were selected for study. Each
reoperation for several patients who underwent ter-
tiary operations, or bilateral reoperations, was con-
sidered separately for the purpose of analysis.
Because the focus of this article was to be the surgi-
cal technique used specifically in the redo surgery,
patients were included for analysis regardless of
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whether their primary operation was performed at
our institution or elsewhere. Also, because the focus
was to be the techniques used for reconstruction of
the internal carotid artery in redo surgery, the
carotid reoperations that did not involve the recon-
struction of the internal carotid artery (ie, external
carotid artery endarterectomy or bypass grafting,
internal carotid artery ligation) were not included
for analysis. Data with regard to demographics, sur-
gical techniques, and perioperative complications
were available for all the patients. The determination
of the cause of recurrent disease was made by
reviewing the surgeons’ operative notes and the
pathology reports.
All the patients underwent evaluation before
surgery with duplex scanning. Most of the patients
underwent preoperative cerebral arteriography. In
the most recent years of this study, a few select
patients, with relative contraindications to conven-
tional angiography, underwent gadolinium-enhanced
magnetic resonance angiography as a substitute. The
decision of which method of arterial reconstruction
to use was made during surgery at the judgment of
the operating surgeon. Patch angioplasty often was
chosen when redo endarterectomy was deemed ade-
quate or when a smooth area of stenosis was caused
by neointimal hyperplasia. Replacement of the artery
often was chosen when redo endarterectomy was
deemed to not be technically feasible or when the
destruction or degeneration of the native arterial wall
precluded its use as a conduit. All the saphenous
veins were harvested from the thigh.
A perioperative stroke was defined as any new per-
manent neurologic deficit that appeared in the peri-
operative period or as a new infarction that appeared
on a computed tomographic or magnetic resonance
scan of the brain. A cranial nerve injury was consid-
ered to have occurred when the appropriate symp-
toms in a patient prompted further clinical evalua-
tion, including otolaryngologic evaluation and direct
laryngoscopy, with which an injury was confirmed.
Perioperative myocardial infarction was defined as
any clinical symptoms in a patient consistent with
myocardial infarction, accompanied by appropriate
electrocardiographic findings or cardiac enzyme
increases. All the patients with cardiac histories
underwent treatment with postoperative surveillance
cardiac enzymes and electrocardiograms, regardless
of the absence of symptoms. Follow-up data, includ-
ing clinical examinations and duplex scan results,
were gathered from the office and hospital charts.
Late failure of redo surgery was defined as any new
clinical ipsilateral hemispheric stroke, any new radio-
logic ipsilateral hemispheric infarction, or any duplex
scan examination that revealed a secondary recurrent
stenosis of >50%, including total occlusion. The
duplex criteria in our laboratory for defining a steno-
sis of at least 50% include spectral broadening, sys-
tolic velocity of more than 120 cm/s, and peak sys-
tolic velocity of more than 140 cm/s. The criteria for
defining a stenosis approaching 79% included an 
end diastolic velocity of 110 to 124 cm/s. The ves-
sels with an end diastolic velocity of more than 125
cm/s were characterized in the 80% to 99% stenotic 
range.
If a duplex scan is not performed, the asympto-
matic recurrent stenosis will go undetected. Therefore,
in an analysis of secondary recurrent stenosis and late
failure rates, only the arteries that had undergone 
follow-up duplex scan examinations were included in
the denominator.
All the data were analyzed by means of the statisti-
cal software package SPSS (SPSS Inc, Chicago, Ill).
The categoric variables between groups were com-
pared with the c 2 test of the Fisher exact test where
appropriate. The life-table comparisons were per-
formed with the generalized Wilcoxon rank sum test.
A result was considered statistically significant with a 
P value of less than .05.
RESULTS
Study population. Analysis was performed on
74 patients who underwent 82 carotid reoperations.
Three patients underwent bilateral carotid reopera-
tions; three patients underwent unilateral secondary
and tertiary reoperations; and one patient under-
went bilateral reoperations and a tertiary operation
on one side. Of the 74 patients, 49 underwent pri-
mary carotid surgery at New York University
Medical Center. The remaining 25 patients under-
went the first carotid operation at various other
institutions.
Patient demographics/risk factors. The patient
population consisted of 39 men (52.7%) and 35
women (47.3%). The mean age of the patients at the
time of the first reoperation that was included in the
analysis was 67.5 years (range, 41 to 85 years). The
mean age of the patients at the time of the primary
carotid endarterectomy was 62.6 years (range, 40 to
81 years). The frequencies of atherosclerotic risk fac-
tors in this population were as follows: 54.1% of the
patients had hypertension, 17.6% had diabetes melli-
tus, 45.9% had coronary artery disease, and 40.5%
were current or past cigarette smokers.
Interval to redo surgery. The mean interval
from the original carotid operation to the redo
carotid surgery was 53 months (range, 2 to 163
months). For cases that were found to have neointi-
mal hyperplasia, the mean interval was 13.6 months
(range, 3 to 44 months). For cases with other caus-
es of recurrent stenosis, including recurrent athero-
sclerosis, the mean interval was 83.4 months (range,
3 to 163 months). For recurrent atherosclerosis
alone, the mean interval was 90.4 months (range, 13
to 163 months). The lesion that recurred at 13
months was designated as recurrent atherosclerosis
on the basis of operative and pathologic findings.
The next shortest interval to recurrent atherosclero-
sis was at 45.7 months.
Indications for redo surgery. The indications
for redo surgery included transient ischemic attack
(TIA) or amaurosis fugax in 29 cases (35.3%), stroke
in five cases (6.1%), and asymptomatic severe
restenosis (>80%) in 48 cases (58.5%).
The status of the contralateral artery by means of
duplex scanning was as follows: <50% stenotic in 13
cases (15.8%), 50% to 79% stenotic in 24 cases
(29.3%), 80% to 99% stenotic in 7 cases (8.5%),
totally occluded in 14 cases (17.1%), and previously
operated and without stenosis in 24 cases (29.3%).
Pathology of recurrent disease. The following
pathologies of recurrent carotid disease were seen:
recurrent atherosclerosis in 39 cases (47.5%), neointi-
mal hyperplasia in 32 cases (39.0%), vein patch
aneurysm in six cases (7.3%), laminated thrombus
without other clear cause in one case (1.2%), and inde-
terminate or unclear in 4 cases (4.9%). Preoperative
symptoms were more frequently present in patients
who were found to have recurrent atherosclerosis than
in those who were found to have intimal hyperplasia—
although not to a statistically significant degree (47.4%
vs 28.1%; P = .10). The cases with intimal hyperplasia
were more likely to be repaired with patch angioplasty
(as opposed to interposition grafting) than recurrent
atherosclerosis cases but not significantly so (65.6% vs
53.8%; P = NS).
Intraoperative factors. Most of the cases were
performed with regional anesthesia (54 operations;
65.8%). A policy of selective shunting was used, and
43 of these 54 cases were performed without a shunt
(79.6%). In the remaining 11 procedures (20.4%),
clamping was not tolerated and a shunt was used.
General anesthesia was used in 28 operations
(34.2%). Routine shunting was used in 23 of the
general anesthesia cases. Of the remaining five cases
that were performed without a shunt, three patients
were previously known to tolerate clamping and two
cases were performed with electroencephalographic
(EEG) monitoring.
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Intraoperative angiography results revealed a patent
reconstruction with no evidence of embolization. The
patient’s hemiparesis slowly improved in the postop-
erative period.
One perioperative TIA occurred in the last
patient who was described above (1.2%). This was
clearly associated with thrombus formation at the
site of a vein patch angioplasty. However, after the
re-exploration, the patient had no neurologic deficit
and no further transient events.
There were no perioperative mortalities and no
myocardial infarctions. There was one clinically sig-
nificant but transient cranial nerve (hypoglossal)
injury (1.2%).
Follow-up period: late results and failures.
Long-term clinical follow-up was obtained in all the
cases, with a mean duration of 35 months (range, 1
to 150 months). Follow-up duplex scan examina-
tions were obtained in 66 patients (89.2%). Of the
eight patients in whom no follow-up duplex scan
was obtained, four died without any clinical evidence
of a stroke and one is currently known to be alive
and well without any clinical evidence of a stroke.
The remaining three patients were known to be alive
and well without stroke for some time after their
redo surgery but have since been lost to follow-up.
The following mean follow-up periods for vari-
ous subgroups were obtained: interposition graft
cases, 24 months; patch angioplasty cases, 43
months; reconstructions performed with vein, 36
months; and reconstructions performed with pros-
thetic material, 26 months.
Late failure of redo surgery was defined as >50%
secondary recurrent stenosis, total occlusion of the
operated artery, or late hemispheric stroke. Late fail-
ures occurred in nine cases (11.0%). Five total occlu-
sions occurred—four were asymptomatic and one
was associated with TIA. Four secondary recurrent
stenoses occurred—three were associated with TIA
or amaurosis fugax and one was asymptomatic. No
patient had a clinically evident late TIA or stroke
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Methods of arterial reconstruction (Table I).
Conventional patch angioplasty with or without
redo endarterectomy was performed in 47 cases
(57.3%). Interposition grafting was performed in 35
cases (42.7%).
Perioperative results and complications.
Three perioperative strokes (3.7%) occurred. The
first patient with stroke underwent bilateral carotid
endarterectomies in 1986. His right internal carotid
artery subsequently was found to be totally occlud-
ed. He underwent redo left carotid surgery in 1996
for a recurrent left carotid stenosis associated with
TIA. This was performed with regional anesthesia
without a shunt. The reconstruction was performed
with a Dacron interposition graft. In the periopera-
tive period, the patient had a right brain stroke,
which was contralateral to the side of surgery.
The second patient underwent a left carotid
endarterectomy in 1995. He was seen 1 year later
with TIA associated with severe recurrent stenosis.
He underwent a redo left carotid surgery in 1996.
The reconstruction was performed with general
anesthesia with a Dacron interposition graft with a
shunt. After surgery, the patient was noted to have
confusion and slurring of speech. He was returned
to the operating room for re-exploration, where a
small amount of thrombus was noted adherent to
one of the suture lines. After the re-exploration, a
partial recovery occurred.
The third patient underwent a left carotid endar-
terectomy in 1973 and a right carotid endarterectomy
in 1985. In 1986, he was found to have total occlusion
of the left carotid artery and asymptomatic severe
recurrent stenosis of the right. He underwent a redo
right carotid endarterectomy with vein patch angio-
plasty in 1986. This was performed with regional anes-
thesia, without a shunt. In the immediate postopera-
tive period, he had a transient episode of left hand
paralysis. A re-exploration of the repair was performed,
with the retrieval of a small amount of platelet aggre-
gate and thrombus and the repair of a suture line. The
patient awoke from the re-exploration with a complete
recovery. In 1991, he again was noted to have asymp-
tomatic severe recurrent stenosis of the right carotid
artery. He underwent tertiary surgery, which consist-
ed of replacement of the artery with a polytetrafluo-
roethylene (PTFE) interposition graft. The surgery
was performed with general anesthesia with EEG
monitoring. Although the EEG results remained nor-
mal throughout the procedure, the patient awoke
with paralysis of the contralateral hand. A re-explo-
ration was performed immediately. These results
revealed no thrombus or apparent technical deficits.
Table I. Techniques of repair used in secondary
carotid operations
Patch Interposition 
Material angioplasty (%) grafting (%) Totals (%)
Vein 26 (31.7) 9 (11.0) 35 (42.7)
Dacron 15 (18.3) 10 (12.2) 25 (30.5)
PTFE 6 (7.3) 16 (19.5) 22 (26.8)
Totals 47 (57.3) 35 (42.7) 82 (100.0)
PTFE, Polytetrafluoroethylene.
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without evidence of carotid restenosis. Four patients
with secondary recurrent stenoses underwent ter-
tiary redo surgery.
Factors that affect the perioperative neurolog-
ic complication rate (Table II). Because the partic-
ular TIA that occurred in this series was significant
enough to prompt re-exploration and because a tech-
nical problem with the arterial reconstruction was dis-
covered and repaired, this episode was included as a
significant perioperative neurologic complication in
statistical analysis. It can be inferred that without re-
exploration and revision, this patient would have had
further embolization or thrombosis and would have
had a stroke. Because this technical problem clearly
resulted from the method of arterial reconstruction,
which was the focus of this study, we felt that it would
have been inappropriate to delete this patient from
the perioperative complication analysis.
The cases in which repair was performed with
interposition grafting were more likely to result in a
perioperative neurologic complication than those in
which patch angioplasty was used, although this was
not statistically significant (8.6% vs 2.1%; P = NS).
The cases in which reconstruction was performed
with prosthetic material were more likely to result in
a perioperative neurologic complication than those
performed with vein, although this result was not sta-
tistically significant (6.4% vs 2.9%; P = NS).
The cases in which the cause of disease was
recurrent atherosclerosis were more likely to be
complicated with a perioperative stroke than those
with intimal hyperplasia. However, this was not sig-
nificantly so (5.1% vs 3.1%, P = NS).
Factors that affected the late complication
rate (Table II). The cases in which repair was per-
formed with patch angioplasty were more likely
overall to result in a late failure of redo surgery than
the interposition graft cases, although this result was
not statistically significant (14.6% vs 9.4%; P = NS).
The cases in which reconstruction was performed
with vein had an overall significantly higher rate of
late failures (stroke, TIA, secondary recurrent steno-
sis, or occlusion) than those in which reconstruction
was performed with any prosthetic material (26.7%
vs 2.3%; P = .002 by Fisher exact test). The redo
cases for intimal hyperplasia and the redo cases for
recurrent atherosclerosis had nearly equivalent rates
of late failure (9.4% vs 7.7%).
Survival analysis. Survival analysis with the life-
table method was performed with respect to long-
term durability and freedom from late failure.
Comparisons were performed between vein recon-
structions and prosthetic reconstructions. At 36
months, the cumulative percentage of vein repairs
that were free of late failure was 83.5% and the
cumulative percentage of prosthetic repairs that
were free of late failure was 93.9%. This comparison
was not statistically significant.
Similar comparisons were performed between
patch angioplasty and graft reconstructions with
respect to late failures. The freedom from late failure
for both of these groups appeared to be nearly
equivalent at 18 months. After this time period, so
few graft reconstructions have been followed that
the comparison was not meaningful.
DISCUSSION
There has been intense interest in recurrent
carotid artery stenosis after prior endarterectomy
ever since its initial report by Stoney and String11 in
1976. Despite this interest, the incidence rate of
recurrent carotid disease after previous endarterecto-
my remains unclear.3 Although carotid endarterecto-
my appears to be a durable procedure, rates of recur-
rent disease as high as 36% have been reported.5,11-14
Investigators have focused on elucidating contributo-
ry risk factors, such as cigarette smoking, hypercho-
lesterolemia, and female gender.15,16 Other investi-
gators have concentrated on the surgical techniques
that may reduce the incidence rate of recurrent
stenosis, with patch closure during primary carotid
endarterectomy frequently being addressed.17-20
The clinical significance of recurrent carotid
stenosis remains an area of controversy. Some authors
Table II. Comparison of outcome with respect to surgical techniques and materials
Patch angioplasty Interposition grafting With vein With prosthetic
(n = 47) (n = 35) P value (n=47) (n = 35) P value
Perioperative CVA or TIA 2.1% 8.6% .20 2.9% 6.4% .42
Late failure 14.6% 9.4% .38 26.7% 2.3% .002
No. of restenoses >50% 3 1 2 2
No. of total occlusions 3 2 2 3
CVA, Cardiovascular accident; TIA, transient ischemic attack.
believe that the clinical course of recurrent stenosis is
benign, especially when caused by neointimal hyper-
plasia. Several investigators maintain that surgery for
recurrent disease should be reserved only for symp-
tomatic cases.6, 21-25 However, there is also evidence
to the contrary, which supports the hypothesis that
recurrent carotid disease is causally related to late
ipsilateral stroke after carotid endarterectomy.26-28
The arguments for the nonoperative manage-
ment of recurrent carotid stenoses are on the basis of
the presumed increased risk for perioperative com-
plications that exists with redo cases. An additional
rationale for the nonoperative management of early
recurrent stenoses, in particular, is on the basis of
the hypothesis that the lesions of neointimal hyper-
plasia simply do not carry the same embolic poten-
tial as atherosclerotic lesions. In our practice, how-
ever, we have believed that similar surgical indica-
tions should be used for secondary carotid surgery as
are used for primary carotid endarterectomy.
Certainly, we have seen patients with early recur-
rences caused by neointimal hyperplasia who were in
fact symptomatic; in this series, 28.1% of the patients
who were found to have intimal hyperplasia at reop-
erative surgery manifested preoperative symptoms.
With recurrent atherosclerotic disease, these lesions
can clearly carry all the same characteristics of pri-
mary carotid lesions that predispose them toward
embolization and stroke. Currently, we have no
accurate way of differentiating which highly stenotic
lesions will cause a stroke and which will not.
Therefore, we have chosen to reoperate on sympto-
matic restenoses (>50%) that cause ipsilateral TIA or
stroke and on asymptomatic restenoses that are pre-
occlusive (>80%). With a low perioperative compli-
cation rate, the risk-benefit ratio with this approach
should remain appropriate.
There are many excellent reports of operative
series for recurrent carotid stenosis.3,4,7,8,15,24,28-44
Most of these reports have found only minimally
increased perioperative morbidity rates associated
with reoperative carotid surgery. However, the long-
term durability of redo carotid surgery has not been
extensively examined; the follow-up of patients with
serial duplex scan examinations is often lacking. The
ideal surgical technique to use in redo carotid
surgery is also unknown. In nearly all the reported
surgically treated cases of recurrent carotid stenosis,
patch angioplasty with or without redo endarterec-
tomy was used.
Certainly, analysis of these data is retrospective
and therefore suffers from well-known limitations.
In addition, the exact choice of which method of
arterial reconstruction to use was made by the indi-
vidual surgeon during surgery rather than prospec-
tively. However, we believe we have demonstrated
some preliminary differences in outcome between
the different surgical techniques used. Furthermore,
it should be emphasized that with this relatively
small number of cases, it may be difficult to show
statistical significance when a difference does, in fact,
exist (type II error).
Our overall perioperative complication rate was
relatively low, with a combined permanent stroke
and death rate of 3.7%. It is notable that, of the
three patients who sustained perioperative strokes,
two were symptomatic before surgery. The other
stroke occurred during a tertiary operation for an
asymptomatic critical high-grade stenosis contralat-
eral to a totally occluded artery. One of the periop-
erative strokes was in the territory of a contralateral
totally occluded artery. All three strokes occurred in
arteries that were reconstructed with interposition
grafts—two with Dacron and one with PTFE. The
one perioperative TIA, a case in which a vein patch
angioplasty was performed, appeared to be related
to platelet aggregation and thrombus formation
adherent to a suture line.
Reconstructions that were performed with
saphenous vein were somewhat less likely to result in
a perioperative neurologic complication than the
prosthetic reconstructions, although not significant-
ly so. Also, the interposition grafts were more likely
to result in a perioperative neurologic complication
than the patch angioplasties, although not signifi-
cantly so. If the perioperative TIA included in the
analysis was removed, the statistical analysis would,
in fact, reveal a significantly higher perioperative
stroke rate with interposition grafting. The follow-
ing explanations are possible for this concerning
finding: the patients with the worst recurrent disease
may be the ones who undergo interposition grafting;
clamp time may be increased with interposition
grafting; and ligation of the external carotid artery,
in some cases, may leave no safe route for flushing of
blood when the clamps are removed. However, it is
difficult to draw firm conclusions regarding these
issues considering the small number of perioperative
strokes that occurred.
An examination of the durability of redo carotid
surgery revealed a relatively high rate of late failures
(11.0%). However, this is considerably less than the
late failure rate in the previous report from our 
institution (19.5%).3 Interposition grafts were less
likely to result in a late failure of redo surgery,
although this result was not statistically significant.
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Interposition grafts have not been followed for as
long as patch reconstructions, and this may account
for the differences seen. Longer follow-up periods
will certainly be necessary to establish this outcome
with certainty. However, this trend, along with the
overall improved long-term results in this series,
appears to support the shift toward performing redo
surgery with interposition grafts, especially with
regard to long-term durability.
An unexpected result from our data is the fact
that vein reconstructions were significantly more
likely to result in a late failure of redo surgery than
were reconstructions that used any prosthetic mater-
ial. To date, only one prosthetic graft and no pros-
thetic patch angioplasties have shown evidence 
of late failure. All the saphenous veins were harvest-
ed from the thigh, and all were thought to be of 
adequate caliber and quality. If an adequate vein 
was unavailable, a prosthetic material was chosen. A
precise explanation for this finding is difficult.
However, we have noted that recurrent carotid dis-
ease often occurs exactly at the previous endarterec-
tomy site. Perhaps the patients in whom recurrent
stenoses develop are, for some reason, innately more
prone toward the development of a recurring lesion
in this precise location of the artery. If the intima is
so predisposed, then performing an interposition
graft to effectively remove this particular part of the
internal carotid artery from the circulation would
appear to make some sense. One could further
hypothesize that, in these patients who are predis-
posed, even an arterialized vein graft could be sus-
ceptible to recurrent disease in this exact location.
The use of a prosthetic material may inhibit this
process. Alternatively, there may be some mechanical
advantage to prosthetic materials in the neck itself.
There is evidence that synthetic grafts are superior to
vein grafts in the carotid-subclavian bypass graft as
well.45,46 Most likely, both host and technical or
mechanical factors play a role in this process.
Other investigators have noted the use of carotid
resection and interposition graft reconstruction for
both difficult primary carotid surgery and recurrent
stenoses.36,41-44,47 Most of these reports have shown
good results with interposition grafting, in general,
and prosthetic grafts, in particular. Mansour et al36
have reported the use of PTFE grafts in 20 redo pro-
cedures. None of these grafts have undergone throm-
bosis, and only one has developed secondary recur-
rent stenosis at 23 months of follow-up. Raithel41 has
used PTFE interposition grafts for recurrent stenoses
and has reported no secondary recurrent stenoses to
date. Rosenthal et al42 reported a series of 31 tertiary
operations for secondary recurrent stenosis. Carotid
resection with vein interposition grafting was per-
formed in 10 patients. They noted that carotid resec-
tion with a vein graft appeared more durable than
patch angioplasty, with none of the interposition graft
cases developing further recurrent stenosis. Treiman
et al43 had a preference for carotid resection for recur-
rent stenosis on the basis of their concern with the
durability of repeat endarterectomy. They compared
57 vein grafts with 105 repeat endarterectomies with
Dacron patch angioplasty. These authors found that
secondary recurrent symptomatic stenosis was more
likely to develop in patients who underwent treat-
ment with repeat endarterectomy than in those who
underwent carotid replacement. Nevertheless, Sise et
al44 reported that one third of nine patients who
underwent PTFE interposition grafting for recurrent
carotid stenosis had a secondary recurrence develop.
CONCLUSION
Reoperative carotid artery surgery can be per-
formed safely with low complication rates. The use of
autologous material for redo carotid surgery appears to
significantly increase the rate of subsequent recurrent
stenosis or total occlusion of the operated artery. The
reason for this finding is unclear but is likely related to
both host and technical factors. The use of prosthetic
material may be preferable in these cases. Interposition
grafting for redo carotid surgery may increase the peri-
operative neurologic complication rate to some
degree. However, this was not statistically significant in
this series. Interposition grafting may be a more
durable solution in long-term follow-up than redo
endarterectomy and patch angioplasty. Longer follow-
up periods will be needed to confirm this conclusion.
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Dr David Rosenthal (Atlanta, Ga). This report by Dr
Rockman, who represents the New York University group,
is one of many from a center with a tradition of excellence
in carotid artery disease. It addresses a concern that faces
all of us: how to best manage the patient who needs a
reoperation of the carotid artery.
I have a few questions and a proposal. As you men-
tioned, Dr Rockman, almost two thirds of the reopera-
tions performed in this study were on patients who were
asymptomatic and had stenoses of 80% or more. The peri-
operative stroke and death rate was 4%. During 10 years of
follow-up, four recurrent carotid stenoses and five occlu-
sions occurred, for a combined perioperative and late fail-
ure rate of 15%. This type of honest information is impor-
tant and raises, yet again, the question of how aggressive
we should be when recommending a reoperation for
asymptomatic restenoses. I believe caution is warranted in
this setting. I wondered, with the sensitivity of color-flow
ultrasound scan or the work from your center on magnet-
ic resonance arteriography, can we not today safely follow
patients who are asymptomatic with a 75% to 80% steno-
sis, or are you still operating on such patients?
Your data also showed saphenous vein to be the best
patch, yet you had an increased incidence rate of late fail-
ures, recurrent stenoses, or occlusions when saphenous
vein was used as an interposition graft. This is intriguing,
and I wonder whether it could be that the vein interposi-
tion cases simply represented the most difficult cases. For
example, during a redo carotid operation when patch
angioplasty proves too difficult because the luminal sur-
face is too diseased or the artery wall is too scarred or thin,
I replace the carotid artery with the most time-honored
material—saphenous vein. When the surgeon was faced
with such an operation, he may have simply said, “We have
a problem. We had better replace the artery with vein.”
And second, could the harvest site affect the late patency
of the interposition grafts? Were any of the interposition
grafts ankle veins?
Finally, I have a proposal. We have just heard an excel-
lent presentation from an institution where 16 years of
high-volume carotid surgery yielded 82 redo carotid oper-
ations. Is it time that we put our best efforts into a nation-
al data retrieval system to collate large series of patients,
which would allow us to finally resolve many of the con-
troversies we seem to revisit annually? Could you imagine
a report from the North American Chapter of the
International Society for Cardiovascular Surgery and the
Society for Vascular Surgery evaluating the perioperative
and long-term results of redo carotid artery surgery? We
could have a report on a thousand patients, which would
solve many of the controversies to face the next generation
of vascular surgeons. I urge our executive councils to con-
sider such a proposal, possibly through the clinical arm of
the Lifeline Foundation. Until then, conscientious,
sophisticated reports, such as this, will serve to guide us.
Dr Rockman, I understand this was your first report at
the national meetings, and we trust not your last.
Congratulations, you did yourself proud.
Dr Caron B. Rockman. Thank you for your com-
ments, Dr Rosenthal. I would like to reiterate that we share
your concern about operating on patients who are asymp-
tomatic in these obviously higher risk cases. However, I
would also like to point out that a patient who is asympto-
matic is only asymptomatic until they have a symptom. In
this report, as I mentioned before, even 30% of the patients
who had intimal hyperplasia, which many people consider
benign, were having some sort of ipsilateral neurologic
symptom that prompted the redo surgery.
Similarly, in Dr. Hobson’s report on recurrent steno-
sis, nearly 50% of the patients on whom he reported with
presumed intimal hyperplasia were also manifesting symp-
toms. Unfortunately, right now, we have no way of know-
ing which highly stenotic lesion will cause a stroke and
which will not. And I think with an acceptably low com-
plication rate from the surgery that this approach is still
justified.
With regard to the vein cases, I should have men-
tioned that all of these were thigh vein harvests. And I do
not think this is really a problem of inadequate vein or
inadequate conduits. Certainly, we have no problem with
using prosthetic material for grafts at our institution. I
think that if a surgeon thought that the vein was inade-
quate, then he certainly would have turned to a prosthet-
ic material.
I do not have a good explanation of why the veins
seem to fare worse in this study. But there is evidence from
other studies that prosthetic grafts function better in the
neck, for example, in the carotid subclavian bypass graft.
Perhaps this is some sort of mechanical problem that we
cannot elucidate.
With regard to your proposal about a national data-
base, we would certainly agree with it. Even at our insti-
tution, it did take quite a number of years to accumulate
these patients.
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Dr John J. Ricotta (Stony Brook, NY). Dr Rockman,
that was a nice presentation. I just wanted to ask about the
patients with stroke. These patients have an increased ath-
erosclerotic burden, as you had shown, and there was
bilateral disease in many of these patients. What was the
cause of the stroke, and could these have been hypoperfu-
sion strokes at the time of surgery? And if so, is there any
correlation between electroencephalographic changes or
the use of a shunt and the fact that it might be harder to
use a shunt in a vein bypass graft than it would be in a
patch angioplasty?
Dr Rockman. I can tell you about the details of these
perioperative strokes if you are interested. The first patient
was having transient ischemic attacks before surgery and had
a contralateral total occlusion. In this patient, the surgery
was performed while the patient was awake with neurologic
monitoring and without a shunt, but the patient actually had
a stroke on the contralateral side appropriate to the con-
tralateral occlusion. So, certainly that may have been some-
what a result of cerebral hypoperfusion during clamping.
The second patient also was having transient ischemic
attacks before surgery but underwent surgery with gener-
al anesthesia with a shunt in place and a Dacron interposi-
tion graft performed over the shunt. This patient awoke
with a neurologic deficit and was re-explored and found to
have platelet aggregates adherent to the repair. So, this
certainly appeared to be a technical error or problem.
The third case, the tertiary operation, which was on a
patient who was asymptomatic with a contralateral total
occlusion, was performed with general anesthesia with
electroencephalographic monitoring. And despite main-
taining a normal electroencephalographic response during
the case, the patient awoke with a hemiparesis. This
patient was re-explored and no technical error was found.
Angiographic results did not reveal a deficit, so it appears
that this may have been caused by hypoperfusion as well.
Dr Thomas F. O’Donnell, Jr (Boston, Mass). This
was a nice paper. Can we focus on the 39% of the patients
with intimal hyperplasia, about which I have several quick
questions.
First, can you describe the technique in which you
“patched” and performed an endarterectomy? Do you
also debulk the lesion?
And secondly, did you analyze the influence of the
intimal hyperplasia group on recurrence, which you define
at a low threshold point of 50%?
And finally, because 50% of your population were
women, did you look at effect of gender on recurrence?
Dr Rockman. Thank you for those questions. To
answer the question, yes, we did look at whether the
patients with intimal hyperplasia had a higher incidence
rate of late failure and found that they did not. The inci-
dence rate of late failure in the intimal hyperplasia cases
was 9.4% as compared with 7.7% with recurrent athero-
sclerosis. This was not statistically significant.
All the cases, except two, in this series were, in fact,
redo endarterectomies or debulking of the hyperplastic
lesion. Two remaining cases were simply patch angioplas-
ty over a smooth hyperplastic surface.
Gender was not specifically examined in this series,
which focused mainly on surgical techniques.
Dr Ramon Berguer (Detroit, Mich). Dr Rockman, I
enjoyed your paper, not the least because the experience
that you report is remarkably similar to ours. In particu-
lar, this was because we had eight patients who had a sec-
ond or third operation in our group of 87 patients with
restenosis. In all the patients who had a second or third
redo operation, the previous operation had been an
autogenous vein. None of the patients in whom we
replaced the carotid artery with a polytetrafluoroethyl-
ene bypass graft had the grafts stenose or occlude during
the average follow-up period. So, I heartily agree with
your conclusions.
Dr Rockman. Well, we certainly agree with you, Dr
Berguer.
Dr Peter Dovgan (Farmington Hills, Mich). I enjoyed
your paper. I am curious that you did not mention any cra-
nial nerve injuries that occurred in your group. Were there
no cranial nerve injuries?
Dr Rockman. I think I did mention that there was one
clinically significant cranial nerve injury for a rate of 1.2%.
Of course, we were not looking for them prospectively.
This was the only one that I could document in this ret-
rospective review that was clinically apparent. I realize that
it is quite a low number as compared with the literature,
but that is the number that was occluded. 
